PFKFB3 and acute respiratory distress syndrome: 3PO inhibits PFKFB3, a glycolytic activator, thereby suppressing LPS-induced NF-κB-p65 nuclear translocation, reducing endothelial cell glycolysis, inflammation, and permeability, and alleviating ALI.